These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


142 related items for PubMed ID: 1703153

  • 1. Cellular attachment to thrombospondin. Cooperative interactions between receptor systems.
    Asch AS, Tepler J, Silbiger S, Nachman RL.
    J Biol Chem; 1991 Jan 25; 266(3):1740-5. PubMed ID: 1703153
    [Abstract] [Full Text] [Related]

  • 2. Human platelet glycoprotein IIIb binds to thrombospondin fragments bearing the C-terminal region, and/or the type I repeats (CSVTCG motif), but not to the N-terminal heparin-binding region.
    Catimel B, Leung L, el Ghissasi H, Mercier N, McGregor J.
    Biochem J; 1992 May 15; 284 ( Pt 1)(Pt 1):231-6. PubMed ID: 1376110
    [Abstract] [Full Text] [Related]

  • 3. Platelet thrombospondin mediates attachment and spreading of human melanoma cells.
    Roberts DD, Sherwood JA, Ginsburg V.
    J Cell Biol; 1987 Jan 15; 104(1):131-9. PubMed ID: 3793757
    [Abstract] [Full Text] [Related]

  • 4. Cell-binding domain of endothelial cell thrombospondin: localization to the 70-kDa core fragment and determination of binding characteristics.
    Dardik R, Lahav J.
    Biochemistry; 1991 Sep 24; 30(38):9378-86. PubMed ID: 1716458
    [Abstract] [Full Text] [Related]

  • 5. Human carcinoma cells bind thrombospondin through a Mr 80,000/105,000 receptor.
    Yabkowitz R, Dixit VM.
    Cancer Res; 1991 Jul 15; 51(14):3648-56. PubMed ID: 1712244
    [Abstract] [Full Text] [Related]

  • 6. Diverse mechanisms for cell attachment to platelet thrombospondin.
    Adams JC, Lawler J.
    J Cell Sci; 1993 Apr 15; 104 ( Pt 4)():1061-71. PubMed ID: 8314891
    [Abstract] [Full Text] [Related]

  • 7. Sense and antisense cDNA transfection of CD36 (glycoprotein IV) in melanoma cells. Role of CD36 as a thrombospondin receptor.
    Silverstein RL, Baird M, Lo SK, Yesner LM.
    J Biol Chem; 1992 Aug 15; 267(23):16607-12. PubMed ID: 1379600
    [Abstract] [Full Text] [Related]

  • 8. Epithelial membrane glycoprotein PAS-IV is related to platelet glycoprotein IIIb binding to thrombospondin but not to malaria-infected erythrocytes.
    Catimel B, McGregor JL, Hasler T, Greenwalt DE, Howard RJ, Leung LL.
    Blood; 1991 Jun 15; 77(12):2649-54. PubMed ID: 1710515
    [Abstract] [Full Text] [Related]

  • 9. Human microvascular endothelial cells adhere to thrombospondin-1 via an RGD/CSVTCG domain independent mechanism.
    Chen ZS, Pohl J, Lawley TJ, Swerlick RA.
    J Invest Dermatol; 1996 Feb 15; 106(2):215-20. PubMed ID: 8601718
    [Abstract] [Full Text] [Related]

  • 10. Cell-type specific adhesive interactions of skeletal myoblasts with thrombospondin-1.
    Adams JC, Lawler J.
    Mol Biol Cell; 1994 Apr 15; 5(4):423-37. PubMed ID: 7519904
    [Abstract] [Full Text] [Related]

  • 11. Activation of human neutrophils increases thrombospondin receptor expression.
    Suchard SJ, Boxer LA, Dixit VM.
    J Immunol; 1991 Jul 15; 147(2):651-9. PubMed ID: 1712815
    [Abstract] [Full Text] [Related]

  • 12. Thrombospondin binds normally to glycoprotein IIIb deficient platelets.
    Kehrel B, Kronenberg A, Schwippert B, Niesing-Bresch D, Niehues U, Tschöpe D, van de Loo J, Clemetson KJ.
    Biochem Biophys Res Commun; 1991 Sep 16; 179(2):985-91. PubMed ID: 1716890
    [Abstract] [Full Text] [Related]

  • 13. Thrombospondin-induced adhesion of human keratinocytes.
    Varani J, Nickoloff BJ, Riser BL, Mitra RS, O'Rourke K, Dixit VM.
    J Clin Invest; 1988 May 16; 81(5):1537-44. PubMed ID: 2452837
    [Abstract] [Full Text] [Related]

  • 14. Thrombospondin binds to the surface of human osteosarcoma cells and mediates platelet-osteosarcoma cell interaction.
    Clezardin P, Serre CM, Trzeciak MC, Drouin J, Delmas PD.
    Cancer Res; 1991 May 15; 51(10):2621-7. PubMed ID: 1708697
    [Abstract] [Full Text] [Related]

  • 15. A single chain 19-kDa fragment from bovine thrombospondin binds to type V collagen and heparin.
    Takagi J, Fujisawa T, Usui T, Aoyama T, Saito Y.
    J Biol Chem; 1993 Jul 25; 268(21):15544-9. PubMed ID: 8340381
    [Abstract] [Full Text] [Related]

  • 16. Motility of human carcinoma cells in response to thrombospondin: relationship to metastatic potential and thrombospondin structural domains.
    Yabkowitz R, Mansfield PJ, Dixit VM, Suchard SJ.
    Cancer Res; 1993 Jan 15; 53(2):378-87. PubMed ID: 8417830
    [Abstract] [Full Text] [Related]

  • 17. CD36 peptides enhance or inhibit CD36-thrombospondin binding. A two-step process of ligand-receptor interaction.
    Leung LL, Li WX, McGregor JL, Albrecht G, Howard RJ.
    J Biol Chem; 1992 Sep 05; 267(25):18244-50. PubMed ID: 1381367
    [Abstract] [Full Text] [Related]

  • 18. Thrombospondin modulates human breast adenocarcinoma cell adhesion to human vascular endothelial cells.
    Incardona F, Lewalle JM, Morandi V, Lambert S, Legrand Y, Foidart JM, Legrand C.
    Cancer Res; 1995 Jan 01; 55(1):166-73. PubMed ID: 7805029
    [Abstract] [Full Text] [Related]

  • 19. Cell attachment to thrombospondin: the role of ARG-GLY-ASP, calcium, and integrin receptors.
    Lawler J, Weinstein R, Hynes RO.
    J Cell Biol; 1988 Dec 01; 107(6 Pt 1):2351-61. PubMed ID: 2848850
    [Abstract] [Full Text] [Related]

  • 20. Heparin-binding peptides from thrombospondins 1 and 2 contain focal adhesion-labilizing activity.
    Murphy-Ullrich JE, Gurusiddappa S, Frazier WA, Höök M.
    J Biol Chem; 1993 Dec 15; 268(35):26784-9. PubMed ID: 8253815
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.